ASCO26: Jennifer Ligibel, MD, BWEL - Takeaways - MDSpire

ASCO26: Jennifer Ligibel, MD, BWEL

Dana-Farber Cancer Institute's Dr. Jennifer Ligibel shared updated results from the BWEL study showing a weight loss intervention led to significantly better physical function, global physical and mental health, and symptom in patients with early breast cancer.

July 1, 2026

Dana-Farber

Share

1

Dr. Jennifer Ligibel presented updated results from the BWEL study at ASCO26.
2

The BWEL study focused on a weight loss intervention for patients with early breast cancer.
3

Results indicated that the weight loss intervention improved physical function in participants.
4

Participants also reported better global physical and mental health following the intervention.
5

The intervention was associated with improved symptom management in early breast cancer patients.